ReviewWorld journal of radiology2026
Machine learning in neuroradiology: Recent developments and applications.
Review in World journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiology, particularly neuroradiology, has become a major focus of research and industrial investment in artificial intelligence and machine learning (ML). These technologies may help address increasing imaging volumes, workforce shortages, and the need for faster and more consistent interpretation. This article summarizes recent developments in ML applications across neuroradiology. In acute ischemic stroke, ML supports early lesion detection, automated Alberta Stroke Program Early Computed Tomography Score assessment, large-vessel-occlusion detection, infarct core and penumbra estimation, collateral evaluation, workflow prioritization, and outcome prediction. Further applications include cerebral aneurysm detection and prediction of intracerebral hemorrhage expansion and prognosis. In neuro-oncology, current uses include tumor segmentation and classification, molecular-marker prediction, treatment-response assessment, surgical and radiotherapy planning, differentiation of recurrence from pseudoprogression, and prognostication. Additional advances involve image reconstruction, automated quantification, diagnostic classification, and outcome prediction in spine imaging; lesion detection and segmentation in demyelinating disease; and identification and characterization of neurodegenerative disorders. Despite this progress, limited generalizability, insufficient external validation, and poor interpretability remain major barriers to clinical adoption. Explainable artificial intelligence, federated learning, and robust multicenter validation are likely to be central to future clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.